Furthermore, TRAIL-based therapy can be combined with immunotherapy (NCT02991196), biological treatment (NCT00400764, NCT00508625), and targeted therapy (NCT01258608, NCT00315757) to improve overall survival (OS) in a variety of cancers [7,92]. This evidence concerns the gene TNFSF10 and cancer.